RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Chongqing Lummy Pharmaceutical Co Stock

Chongqing Lummy Pharmaceutical Co Debt 2024

Chongqing Lummy Pharmaceutical Co Debt

-510.98 CNY

Ticker

300006.SZ

ISIN

CNE100000H10

In 2024, Chongqing Lummy Pharmaceutical Co's total debt was -510.98 CNY, a 12.5% change from the -454.22 CNY total debt recorded in the previous year.

Chongqing Lummy Pharmaceutical Co Aktienanalyse

What does Chongqing Lummy Pharmaceutical Co do?

Chongqing Lummy Pharmaceutical Co Ltd is a leading company in the pharmaceutical products sector. The company was founded in 2001 and is headquartered in Chongqing, China. Its business model focuses on the manufacturing and distribution of pharmaceutical products and medications, including those for the treatment of severe and chronic diseases. Since its establishment, the company has undergone significant development. Through the establishment of research and development departments, the company has been able to develop and manufacture innovative products. This has enabled the company to establish itself as an important player in the market. Chongqing Lummy Pharmaceutical's main products include medications for the treatment of diabetes, cancer, cardiovascular diseases, and mental disorders. The divisions of Chongqing Lummy Pharmaceutical cover various areas of pharmaceutical manufacturing, including the production of tablets, capsules, injection fluids, and ointments. There is also a department specializing in the production of raw materials and active ingredients. This allows Chongqing Lummy Pharmaceutical to control its own value chain and ensure the quality of its products. The company's most well-known products include the insulin injection fluids "Liupanshui," which have been very successful in the Chinese market. The medications "Qiliqiang" and "Jiaonang" for the treatment of breast cancer and the severe acute respiratory syndrome SARS-CoV-2 have also been very successful. The company also has a strong presence in other Asian countries, such as India and Vietnam. Chongqing Lummy Pharmaceutical focuses on quality and innovation. The company holds several certifications and has established a quality assurance system to ensure that all products meet the highest standards. Additionally, the company invests heavily in research and development to bring innovative products to the market. Chongqing Lummy Pharmaceutical also participates in research projects with other companies and institutions to promote collaboration in the pharmaceutical industry. In recent years, the company has achieved strong growth. It has a wide portfolio of products and a strong presence in Asia. In the future, the company plans to further expand its market position and broaden its product range. Chongqing Lummy Pharmaceutical has good chances of establishing itself as a major player in the global market for pharmaceutical products. Chongqing Lummy Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Chongqing Lummy Pharmaceutical Co's Debt Structure

Chongqing Lummy Pharmaceutical Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Chongqing Lummy Pharmaceutical Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Chongqing Lummy Pharmaceutical Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Chongqing Lummy Pharmaceutical Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Chongqing Lummy Pharmaceutical Co stock

What is the debt of Chongqing Lummy Pharmaceutical Co this year?

Chongqing Lummy Pharmaceutical Co has a debt level of -510.98 CNY this year.

What was the debt of Chongqing Lummy Pharmaceutical Co compared to the previous year?

The debt of Chongqing Lummy Pharmaceutical Co has increased by 12.5% compared to the previous year increased.

What are the consequences of high debt for investors in Chongqing Lummy Pharmaceutical Co?

High debt can pose a risk for investors of Chongqing Lummy Pharmaceutical Co, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Chongqing Lummy Pharmaceutical Co?

Low debt means that Chongqing Lummy Pharmaceutical Co has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Chongqing Lummy Pharmaceutical Co affect the company?

An increase in debt of Chongqing Lummy Pharmaceutical Co can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Chongqing Lummy Pharmaceutical Co affect the company?

A reduction in debt of Chongqing Lummy Pharmaceutical Co can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Chongqing Lummy Pharmaceutical Co?

Some factors that can influence the debt of Chongqing Lummy Pharmaceutical Co include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Chongqing Lummy Pharmaceutical Co so important for investors?

The debts of Chongqing Lummy Pharmaceutical Co are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Chongqing Lummy Pharmaceutical Co take to change the debt?

To change the debt, Chongqing Lummy Pharmaceutical Co can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Chongqing Lummy Pharmaceutical Co pay?

Over the past 12 months, Chongqing Lummy Pharmaceutical Co paid a dividend of 0.05 CNY . This corresponds to a dividend yield of about 1.03 %. For the coming 12 months, Chongqing Lummy Pharmaceutical Co is expected to pay a dividend of 0 CNY.

What is the dividend yield of Chongqing Lummy Pharmaceutical Co?

The current dividend yield of Chongqing Lummy Pharmaceutical Co is 1.03 %.

When does Chongqing Lummy Pharmaceutical Co pay dividends?

Chongqing Lummy Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of August, September, August, August.

How secure is the dividend of Chongqing Lummy Pharmaceutical Co?

Chongqing Lummy Pharmaceutical Co paid dividends every year for the past 0 years.

What is the dividend of Chongqing Lummy Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Chongqing Lummy Pharmaceutical Co located?

Chongqing Lummy Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Chongqing Lummy Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Chongqing Lummy Pharmaceutical Co from 7/3/2020 amounting to 0.05 CNY, you needed to have the stock in your portfolio before the ex-date on 7/3/2020.

When did Chongqing Lummy Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 7/3/2020.

What was the dividend of Chongqing Lummy Pharmaceutical Co in the year 2023?

In the year 2023, Chongqing Lummy Pharmaceutical Co distributed 0 CNY as dividends.

In which currency does Chongqing Lummy Pharmaceutical Co pay out the dividend?

The dividends of Chongqing Lummy Pharmaceutical Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Chongqing Lummy Pharmaceutical Co

Our stock analysis for Chongqing Lummy Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chongqing Lummy Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.